These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 31493330)

  • 1. Malignant hyperthermia - what do we know in 2019?
    Cieniewicz A; Trzebicki J; Mayzner-Zawadzka E; Kostera-Pruszczyk A; Owczuk R
    Anaesthesiol Intensive Ther; 2019; 51(3):169-177. PubMed ID: 31493330
    [No Abstract]   [Full Text] [Related]  

  • 2. [Atypical malignant hyperthermia. A higher incidence than expected].
    Herrero E; Casinello F; de Stefano J; Fernández-Guisasola J; Pérez-Gallardo A
    Rev Esp Anestesiol Reanim; 1996 Jan; 43(1):42-3. PubMed ID: 8851836
    [No Abstract]   [Full Text] [Related]  

  • 3. [Helsinki Declaration on Patient Safety in Anaesthesiology - Part 3: SOP for malignant hyperthermia].
    Schuster F; Johannsen S; Roewer N
    Anasthesiol Intensivmed Notfallmed Schmerzther; 2013 Mar; 48(3):162-4. PubMed ID: 23592246
    [No Abstract]   [Full Text] [Related]  

  • 4. Malignant hyperthermia: how to spot it early.
    Haslego SS
    RN; 2002 Jul; 65(7):31-5; quiz 36. PubMed ID: 12136527
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Drug-induced malignant hyperthermia].
    Ichihara Y; Kikuchi H
    Nihon Rinsho; 2007 Oct; 65 Suppl 8():326-30. PubMed ID: 18074557
    [No Abstract]   [Full Text] [Related]  

  • 6. [Anesthesia in hereditary peripheral muscular disease].
    Islander G; Jungner M
    Lakartidningen; 2005 Feb 21-27; 102(8):566-71. PubMed ID: 15786909
    [No Abstract]   [Full Text] [Related]  

  • 7. [Mild variant of malignant hyperthermia following succinylcholine and halogenated agent exposure].
    Fernández-García V; Bermejo MA; Vázquez C; Pereda MJ; Altarriba JM; Alvarez E
    Rev Esp Anestesiol Reanim; 1995 Nov; 42(9):401-2. PubMed ID: 8584782
    [No Abstract]   [Full Text] [Related]  

  • 8. Malignant hyperthermia during desflurane-succinylcholine anesthesia for orthopedic surgery.
    Garrido S; Fraga M; Martín MJ; Belda J
    Anesthesiology; 1999 Apr; 90(4):1208-9. PubMed ID: 10201695
    [No Abstract]   [Full Text] [Related]  

  • 9. [Malignant hyperthermia].
    Glahn KP
    Ugeskr Laeger; 2003 Apr; 165(17):1763-8. PubMed ID: 12768904
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Malignant hyperthermia susceptibility: utilization of genetic results in an electronic medical record to increase safety.
    Baye JF; Petry NJ; Jacobson SL; Moore MM; Tucker B; Shaaban S; Massmann AK; Clark NM; Schultz AJ
    Pharmacogenomics; 2020 Nov; 21(17):1207-1215. PubMed ID: 33118445
    [No Abstract]   [Full Text] [Related]  

  • 11. Use of Optiflow™ nasal high-flow oxygen in a patient with malignant hyperthermia.
    Coulter S; Girgis M
    Br J Anaesth; 2018 Sep; 121(3):680. PubMed ID: 30115272
    [No Abstract]   [Full Text] [Related]  

  • 12. Suspected malignant hyperthermia reactions in New Zealand.
    Pollock AN; Langton EE; Couchman K; Stowell KM; Waddington M
    Anaesth Intensive Care; 2002 Aug; 30(4):453-61. PubMed ID: 12180584
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hyperthermia associated with ophthalmic surgery.
    Beasley H
    Trans Am Ophthalmol Soc; 1973; 71():61-6; discussion 66-9. PubMed ID: 10949590
    [No Abstract]   [Full Text] [Related]  

  • 14. Signs of an MH reaction.
    Khalil SN; Youngblood B; Campos C; Teichgraeber JF
    Paediatr Anaesth; 1999; 9(3):277-8. PubMed ID: 10322104
    [No Abstract]   [Full Text] [Related]  

  • 15. No response to trigger agents in a malignant hyperthermia-susceptible patient.
    Claxton BA; Cross MH; Hopkins PM
    Br J Anaesth; 2002 Jun; 88(6):870-3. PubMed ID: 12173209
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Duchenne muscular dystrophy: Which is the best anesthetic agent?
    Driessen J; Snoeck M
    Paediatr Anaesth; 2008 Oct; 18(10):1007-8. PubMed ID: 18811853
    [No Abstract]   [Full Text] [Related]  

  • 17. Malignant hyperthermia-like syndrome and carnitine palmitoyltransferase II deficiency with heterozygous R503C mutation.
    Hogan KJ; Vladutiu GD
    Anesth Analg; 2009 Oct; 109(4):1070-2. PubMed ID: 19762733
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Anesthesia in malignant hyperthermia].
    Ortiz Gómez JR
    Rev Esp Anestesiol Reanim; 2008 Mar; 55(3):165-74. PubMed ID: 18401991
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human malignant hyperthermia associated with desflurane anesthesia.
    Allen GC; Brubaker CL
    Anesth Analg; 1998 Jun; 86(6):1328-31. PubMed ID: 9620529
    [No Abstract]   [Full Text] [Related]  

  • 20. Unexpected MH deaths without exposure to inhalation anesthetics in pediatric patients.
    Brandom BW; Muldoon SM
    Paediatr Anaesth; 2013 Sep; 23(9):851-4. PubMed ID: 23848295
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.